Colgate‑Palmolive has restructured its geographic reporting by merging its Europe, Africa/Eurasia (excluding Russia and Belarus) and Skin Health businesses into a single EMEA segment, effective for the quarter ending March 31 2026. The company also transferred its Russia and Belarus markets to the Asia Pacific segment, aligning those markets with peers that share similar economic and regulatory environments.
The change is part of the company’s Strategic Growth and Productivity Program, which seeks to streamline operations, improve scale, and reduce administrative overhead. By consolidating these regions, Colgate‑Palmolive expects to unlock cross‑regional synergies and better allocate marketing resources to high‑growth areas. The transfer of Russia and Belarus to Asia Pacific is intended to enhance pricing power and supply‑chain efficiency in those territories.
Over the last twelve months the company generated $20.38 billion in revenue and maintained a 60 % gross‑profit margin. The restructuring does not affect historical consolidated results, but the Strategic Growth and Productivity Program is projected to incur cumulative pre‑tax charges of $200‑$300 million over the next three years.
In a filing with the SEC, CEO Noel Wallace said the realignment is intended to "optimize and leverage operating scale and drive growth within the affected regions." The statement underscores the company’s focus on operational efficiency and market‑specific growth.
The new EMEA unit will allow Colgate‑Palmolive to focus investment on high‑growth opportunities and improve resource allocation across its product portfolio. The realignment also supports the company’s broader 2030 strategy, which emphasizes innovation, digital capabilities, and omni‑channel demand generation, positioning the firm for long‑term competitive advantage.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.